Juzentaihoto Suppresses Muscle Atrophy and Decreased Motor Function in SAMP8 Mice

Yasuyo Morita1, Tomoaki Ishida1, Shumpei Morisawa1,2

  • 1Department of Pharmacy, Kochi Medical School Hospital.

Insights

Juzentaihoto hot water extract (JTT) improved skeletal muscle mass and function in aging mice by increasing Sirt1 and IGF-1 levels, reducing muscle atrophy markers.

Area of Science:

  • Gerontology
  • Muscle Physiology
  • Pharmacology

Background:

  • Sarcopenia, characterized by age-related muscle mass and strength loss, involves increased ubiquitin ligases (Atrogin1, MuRF1) via FOXO and NF-κB pathways.
  • Sirtuin 1 (Sirt1) counteracts muscle atrophy by suppressing NF-κB and FOXO.
  • Insulin-like growth factor-1 (IGF-1) production decreases with age, contributing to sarcopenia.

Purpose of the Study:

  • To investigate the effects of juzentaihoto hot water extract (JTT) on age-related skeletal muscle atrophy and motor function.
  • To explore the underlying molecular mechanisms of JTT's action in senescence-accelerated mouse prone-8 (SAMP8) models.

Main Methods:

  • Administration of JTT to SAMP8 mice.
  • Assessment of gastrocnemius (GA) and extensor digitorum longus (EDL) muscle weights and fiber cross-sectional areas.
  • Evaluation of motor function using rota-rod tests.
  • Measurement of serum IGF-1, tumor necrosis factor-α, and interleukin-6 levels.
  • Quantification of Sirt1, Atrogin1, and MuRF1 mRNA expression in GA muscle.

Main Results:

  • JTT treatment increased GA and EDL muscle weights and GA muscle fiber cross-sectional area.
  • JTT administration improved motor function in SAMP8 mice.
  • JTT elevated serum IGF-1 and GA Sirt1 mRNA levels, while reducing inflammatory cytokines and Atrogin1/MuRF1 mRNA expression.
  • GA muscle fiber cross-sectional area positively correlated with GA Sirt1 mRNA levels.

Conclusions:

  • JTT effectively suppresses skeletal muscle atrophy and motor function decline in SAMP8 mice.
  • The beneficial effects of JTT are likely mediated by increased Sirt1 and IGF-1 expression, alongside reduced ubiquitin ligase activity.